Quantbot Technologies LP trimmed its holdings in Relx Plc (NYSE:RELX – Free Report) by 50.4% during the fourth quarter, Holdings Channel.com reports. The fund owned 15,554 shares of the technology company’s stock after selling 15,776 shares during the period. Quantbot Technologies LP’s holdings in Relx were worth $706,000 at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. CENTRAL TRUST Co lifted its holdings in shares of Relx by 1,290.2% in the fourth quarter. CENTRAL TRUST Co now owns 570 shares of the technology company’s stock valued at $26,000 after purchasing an additional 529 shares in the last quarter. Versant Capital Management Inc acquired a new position in shares of Relx during the 4th quarter worth approximately $31,000. Sierra Ocean LLC purchased a new stake in Relx in the 4th quarter valued at approximately $43,000. Private Trust Co. NA grew its holdings in Relx by 119.9% during the 3rd quarter. Private Trust Co. NA now owns 1,038 shares of the technology company’s stock valued at $49,000 after buying an additional 566 shares during the last quarter. Finally, Whipplewood Advisors LLC purchased a new position in Relx during the fourth quarter worth $74,000. 15.02% of the stock is currently owned by hedge funds and other institutional investors.
Relx Stock Performance
Relx stock opened at $49.93 on Thursday. The stock has a fifty day moving average price of $49.40 and a 200 day moving average price of $47.78. Relx Plc has a 52 week low of $40.25 and a 52 week high of $51.99. The firm has a market capitalization of $92.66 billion, a P/E ratio of 26.84, a PEG ratio of 2.73 and a beta of 0.90. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46.
Relx Increases Dividend
Analyst Ratings Changes
Several analysts have recently issued reports on the company. Redburn Atlantic assumed coverage on Relx in a research report on Wednesday, January 8th. They issued a “buy” rating on the stock. StockNews.com lowered shares of Relx from a “buy” rating to a “hold” rating in a report on Tuesday, March 4th. Barclays upgraded shares of Relx from an “equal weight” rating to an “overweight” rating in a report on Friday, March 14th. Finally, The Goldman Sachs Group assumed coverage on shares of Relx in a research note on Wednesday. They set a “buy” rating on the stock. One equities research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Buy”.
View Our Latest Research Report on RELX
Relx Company Profile
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Featured Stories
- Five stocks we like better than Relx
- What Are Dividend Contenders? Investing in Dividend Contenders
- Energy Transfer: Powering Data With Dividends and Diversification
- Most Volatile Stocks, What Investors Need to Know
- Qualcomm Stock Is Coiling for a Breakout
- Consumer Staples Stocks, Explained
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX – Free Report).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.